Evidence map›Paper›PMID 26023847›Full record

ReviewEpigenetics2015

Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.

Arthur Godino, Subramaniam Jayanthi, Jean Lud Cadet

Open access · bronzeAbstract readReview
In one paragraph

Review in Epigenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 117 citations in OpenAlex.

  1. Trial
  2. Review
  3. The mechanism of the JNK signaling pathway in drug addiction : Author list.Journal of molecular medicine (Berlin, Germany) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. An update: epigenetic mechanisms underlying methamphetamine addiction.Frontiers in cell and developmental biology · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Epigenetic Effects of Addictive Drugs in the Nucleus Accumbens.Frontiers in molecular neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 4 countries.

Arthur Godinoa Département de Biologie; École Normale Supérieure de Lyon ; Lyon , France.
Subramaniam Jayanthi
Jean Lud Cadet
National Institutes of Health · USÉcole Normale Supérieure de Lyon · FR

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Amphetamine and methamphetamine addiction is described by specific behavioral alterations, suggesting long-lasting changes in gene and protein expression within specific brain subregions involved in the reward circuitry. Given the persistence of the addiction phenotype at both behavioral and transcriptional levels, several studies have been conducted to elucidate the epigenetic landscape associated with persistent effects of drug use on the mammalian brain. This review discusses recent advances in our comprehension of epigenetic mechanisms underlying amphetamine- or methamphetamine-induced behavioral, transcriptional, and synaptic plasticity. Accumulating evidence demonstrated that drug exposure induces major epigenetic modifications-histone acetylation and methylation, DNA methylation-in a very complex manner. In rare instances, however, the regulation of a specific target gene can be correlated to both epigenetic alterations and behavioral abnormalities. Work is now needed to clarify and validate an epigenetic model of addiction to amphetamines. Investigations that include genome-wide approaches will accelerate the speed of discovery in the field of addiction.

Indexed as

Disease Models, AnimalAcetylationAmphetamineAmphetamine-Related DisordersAnimalsBehavior, AnimalBrainCentral Nervous System StimulantsEpigenesis, GeneticGene ExpressionHistone DeacetylasesHistonesHumansMethamphetamineMethylationMiceAmphetamineCentral Nervous System StimulantsHistone DeacetylasesHistonesMAS1 protein, humanMethamphetamineProto-Oncogene MasAMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidAMPH, amphetamineamphetamineAP1, activator protein 1ATF2, activating transcription factor 2BASP1, brain abundant signal protein 1BDNF, brain derived neurotrophic factorCCR2, C‒C chemokine receptor 2ChIP, chromatin immunoprecipitationCoREST, restrictive element 1 silencing transcription factor corepressorCp60, compound 60CPP, conditioned place preferenceCREB, cAMP response element binding proteinDNA methylationDNMT, DNA methyltransferaseFOS, Finkel–Biskis–Jinkins murine osteosarcoma viral oncogeneGABA, γ-aminobutyric acidGLUA1, glutamate receptor subunit A1GLUA2, glutamate receptor subunit A2GLUN1, glutamate receptor subunit N1H2Bac, pan-acetylation of histone 2BH3, histone 3H3K14Ac, acetylation of histone 3 at lysine 14H3K18, lysine 18 of histone 3H3K4, lysine 4 of histone 3H3K4me3, trimethylation of histone 3 at lysine 4H3K9Ac, acetylation of histone 3 at lysine 9H3K9, lysine 9 of histone 3H3K9me3, trimethylation of histone 3 at lysine 9H4Ac, pan-acetylation of histone 4H4, histone 4H4K12Ac, acetylation of histone 4 at lysine 12H4K16, lysine 16 of histone 4H4K5, lysine 5 of histone 4H4K8, lysine 8 of histone 4HAT, histone acetyltransferaseHDAC, histone deacetylaseHDM, histone demethylasehistone acetylationhistone methylationHMT, histone methyltransferaseIP, intra-peritonealJUN, jun proto-oncogeneKDM, lysine demethylaseKLF10, Kruppel-like factor 10KMT, lysine methyltransferaseMeCP2, methyl-CpG binding protein 2methamphetamineMETH, methamphetamineNaB, sodium butyrateNAc, nucleus accumbensNMDA, N-methyl-D-aspartateOfC, orbitofrontal cortexPfC, prefrontal cortexREST, restrictive element 1 silencing transcription factorRNAi, RNA interferenceSer241, serine 241Sin3A, SIN3 transcription regulator family member AsiRNA, silencing RNATSS, transcription start siteVPA, valproic acidWT1, Wilms tumor protein 1.

Identifiers

PMID26023847
PMCPMC4622560
OpenAlexW1555852983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.